Drug Discovery and Development: Technology in Transition

Front Cover
H. P. Rang, Daniel Vasella
Churchill Livingstone / Elsevier, 2006 - Medical - 346 pages
This title is directed primarily toward health care professionals outside the United States. An ideal introduction to the pharmaceutical industry, this book describes the process of bringing a new drug to the marketplace. It explains why, although thousands of compounds show initial promise, only a small handful will be developed for human clinical trials and perhaps only one will become an approved drug. Describing the huge complexities involved, it shows how new molecular understanding and techniques can make the process more targeted and successful.

  • Includes the new molecular techniques of drug design and development.
  • Discusses current therapeutic needs.
  • Covers pharmacoepidemiology and pharmacoeconomics.
  • Edited by Humphrey Rang, who is also known throughout the world as a co-author of the enormously successful and authoritative textbook, Pharmacology, now in its fifth edition.
  • Foreword by Daniel Vasella, CEO, Novartis International.
  • Includes contributors from both the pharmaceutical industry and universities.

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

INTRODUCTION AND BACKGROUND DRUG DISCOVERY
6
general principles
45
The nature of disease and the purpose of 5 Choosing the project
57
Copyright

15 other sections not shown

Common terms and phrases

Bibliographic information